{"filing":{"accession_number":"0001640334-26-001421","cik":"0001621221","ticker":"ARTL","company_name":"ARTELO BIOSCIENCES, INC.","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-26","primary_document":"artl_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/artl_8k.htm"},"events":[{"id":29932,"run_id":27430,"accession_number":"0001640334-26-001421","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Artelo Biosciences effected a 1-for-9 reverse stock split of its common stock, effective August 31, 2026, via a Certificate of Change filed with Nevada on August 26, 2026. The reverse split reduced outstanding shares from approximately 4.9 million to 547,774 and authorized shares from 500 million to 55.5 million, materially modifying the rights and structure of the company's securities and affecting all shareholders' holdings and ownership percentages.","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":[{"id":32376,"accession_number":"0001640334-26-001421","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-9 reverse stock split of Artelo's common stock, effected via a Certificate of Change (referenced in Item 5.03 and filed as Exhibit 3.1). This is a material modification to the rights and structure of the company's securities — each shareholder's nine shares automatically combine into one share. While reverse splits are governance/capital structure events rather than operational or financial events in the traditional sense, they materially affect security holders' rights and are typically classified as governance matters when they do not fit more specific categories like dilutive issuance or debt issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32377,"accession_number":"0001640334-26-001421","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports a 1-for-9 reverse stock split effected via a Certificate of Change filed with Nevada on August 26, 2026, reducing outstanding shares from 4.9 million to approximately 547,774 and authorized shares from 500 million to 55.5 million. While Item 5.03 covers amendments to articles and bylaws, the reverse split is a capital structure modification that affects all shareholders' holdings and is material to investor assessment of share count, ownership percentages, and market liquidity—a governance-level capital event that does not fit the specific named categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results, etc.).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32378,"accession_number":"0001640334-26-001421","item_number":"7.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces a 1-for-9 reverse stock split effective August 31, 2026, which is a governance and capital structure event. While reverse splits are routine corporate actions, this one is material to investors as it affects share count, trading price, and marketability. The event does not fit the specific categories of dilutive issuance, dividend distribution, or other named financial events—it is a structural recapitalization that falls under governance matters affecting shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32376,"accession_number":"0001640334-26-001421","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-9 reverse stock split of Artelo's common stock, effected via a Certificate of Change (referenced in Item 5.03 and filed as Exhibit 3.1). This is a material modification to the rights and structure of the company's securities — each shareholder's nine shares automatically combine into one share. While reverse splits are governance/capital structure events rather than operational or financial events in the traditional sense, they materially affect security holders' rights and are typically classified as governance matters when they do not fit more specific categories like dilutive issuance or debt issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-08-27"},{"id":32377,"accession_number":"0001640334-26-001421","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports a 1-for-9 reverse stock split effected via a Certificate of Change filed with Nevada on August 26, 2026, reducing outstanding shares from 4.9 million to approximately 547,774 and authorized shares from 500 million to 55.5 million. While Item 5.03 covers amendments to articles and bylaws, the reverse split is a capital structure modification that affects all shareholders' holdings and is material to investor assessment of share count, ownership percentages, and market liquidity—a governance-level capital event that does not fit the specific named categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results, etc.).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-08-27"},{"id":32378,"accession_number":"0001640334-26-001421","item_number":"7.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces a 1-for-9 reverse stock split effective August 31, 2026, which is a governance and capital structure event. While reverse splits are routine corporate actions, this one is material to investors as it affects share count, trading price, and marketability. The event does not fit the specific categories of dilutive issuance, dividend distribution, or other named financial events—it is a structural recapitalization that falls under governance matters affecting shareholder interests.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T12:32:16.425179+00:00","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-08-27"}]}